SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 21.36-3.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John R. Sashko who wrote (1179)10/16/1997 2:14:00 PM
From: Robert Busse   of 1693
 
Anyone besides me see the front page of USA TODAY regarding genital herpes?? It refers to an article released this morning in the New England Journal of Medicine. Although we can't get the actual article on line w/o a subscription, we can get the editorial at the NEJM website nejm.org it says dx methods for clinical mgmt of HSV-2 "are limited" "Type specific assays for HSV antibodies are not yet available for clinical use. Commercial laboratories often report serologic results according to viral type, but these assays do not differentiate between antibodies elicited by HSV-1 and HSV-2 infection" I faxed this editorial to Qdel today-they hadn't seen it yet. I think it dovetails nicely with their recent announcement about the new Glaxo/Quidel collaboration on herpes test
Also, earnings will be out next week on Wednesday, 10-22-97 - conference call will be held at 1:15 Pacific time (4:15 EST just after thre close of the market). Hope it is good news!!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext